Health Condition 1: A630- Anogenital (venereal) warts
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Newly diagnosed cases for atleast 3 months duration Give informed consent
Exclusion criteria
Exclusion criteria: patients having unrealistic expectations or having psychiatric illness patients with renal, cardiac or hepatic disorders immunocompromised patients Pregnancy and lactating mothers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of cases with complete clearance Time taken for complete clearance Mean change in number of lesions recurrences adverse events Timepoint: at baseline at 4 weeks at 8 weeks, 12 weeks and 16 weeks with a follow up period of 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment sessions required for complete clearance of genital warts. Time taken for complete clearance of genital warts. Mean change from the baseline recurrences and adverse effects Timepoint: 20 weeks 24 weeks 28 weeks 32 weeks post treatment follow up period | — |
Countries
India
Contacts
Government Medical College Amritsar